Wilson P E
Organon Teknika Corp., Durham, NC 27712, USA.
Clin Chem. 1997 Sep;43(9):1716-8.
I describe a method to measure blood coagulation properties, based on the hypothesis that the distance the serum component of a clotted plasma sample moves through a suitable absorbent material should be proportional to the blood's ability to clot. A simple apparatus was constructed to test this principle, in which an absorbent strip contacts clotted plasma samples. At various times, the liquid migration distance into the strip was measured and correlated with clotting times determined by well-accepted procedures. Use of this device to test lyophilized normal and barium-absorbed plasmas, factor VII-deficient plasma, frozen normal plasmas, plasmas from patients undergoing oral anticoagulation, and saline-diluted plasmas (as for Quick Percent assays) showed that clotting times correlated with migration distances for all types of samples (r2 = 0.93-0.99). The device distinguishes between samples from normal and coumadin-treated subjects. The concept can be integrated into an inexpensive, point-of-care coagulation monitor.
我描述了一种测量血液凝固特性的方法,该方法基于这样的假设:凝块血浆样本的血清成分在合适的吸收材料中移动的距离应与血液的凝血能力成正比。构建了一个简单的装置来测试这一原理,其中吸收条与凝块血浆样本接触。在不同时间,测量液体向条带内的迁移距离,并将其与通过公认程序测定的凝血时间相关联。使用该装置测试冻干的正常血浆和钡吸收血浆、因子VII缺乏血浆、冷冻正常血浆、接受口服抗凝治疗患者的血浆以及盐水稀释血浆(如用于Quick百分比测定)表明,所有类型样本的凝血时间与迁移距离相关(r2 = 0.93 - 0.99)。该装置能够区分正常受试者和接受香豆素治疗受试者的样本。这一概念可整合到一种廉价的即时凝血监测仪中。